ATGTTGGCTTATGGTTTGAATGGG-3' and the reverse primer 5'-TGCAGAGACTCAGAAGCAAAGAGC-3', was cloned upstream of the -globin intron. The resulting ER-rtTA fragment of 5.6 kb was released from the backbone by NotI digestion and was microinjected into fertilized oocytes to generate transgenic mice (in the transgenic facility of the Université catholique de Louvain, Brussels, Belgium). 4 transgenic founders were first identified by PCR, out of 34 mice born.
Expression profiles of the ER-rtTA founders were screened with reporter TetOH2B-GFP mice. 1 founder expressed the GFP in cells expressing the endogenous ER, and was used throughout this study.
Targeting H2B-GFP expression. ER-rtTA/TetOH2B-GFP adult female mice were induced by oral administration of doxycycline food diet (1g/kg, BIO-SERV) during 5 days and analyzed at the end of the treatment.
Targeting YFP expression. 4 weeks old ER-rtTA/TetOCre/RosaYFP female mice were induced by oral administration of doxycycline food diet (1g/kg, BIO-SERV) during 5 days, and analyzed at different time points after induction, as specified in figure legends. For saturation experiments, 4 weeks old ER-rtTA/TetOCre/RosaYFP female mice were induced by oral administration of doxycycline food diet (1g/kg, BIO-SERV) combined with doxycycline diluted in drinking water (2g/l, AG Scientific) and 3 intraperitoneal injections per week (200µl of 10mg/ml doxycycline diluted in PBS) during 28 days.
Histology and immunostaining. Dissected MGs were pre-fixed for 2h in 4%
paraformaldehyde at room temperature. Tissues were washed three times with PBS for 5 min and incubated overnight in 30% sucrose in PBS at 4°C. Tissues were embedded in OCT compound (Tissue Tek) and kept at -80°C. 5 µm sections were cut using a HM560 Microm cryostat (Mikron Instrument).
Sections were incubated in blocking buffer (5% horse serum/ 1% bovine serum albumin/ 0,2% Triton in PBS) for 1h at room temperature. Primary antibodies were incubated overnight at 4°C. Sections were rinsed three times for 5 min in PBS and incubated with secondary antibodies in blocking buffer for 1 hour at room temperature. Nuclei were stained With Hoechst 33342 dye (Sigma) and slides were mounted in mounting medium (DAKO) supplemented with 2,5% Dabco (Sigma).
For figures 3D, 3E, 4B and 4G, thick sections of 100 µm were cut and staining was performed as for the 5 µm sections, except that the secondary antibodies were incubated overnight at 4°C instead of 1 hour at room temperature.
The following primary antibodies were used: Anti-ERα (Rabbit, 1/500, sc-542, Santa
Cruz Biotechnology), Anti-K8 TROMA-1 (Rat, 1/1000, Developmental Studies Hybridoma Bank), Anti K14 (Chicken, 1/1000, PRB-155P-0100, Covance), Anti-GFP For BrdU staining, cells suspension from 4w and 10w old CD1 mice injected with 50mg/kg 5-Bromo-2-deoxyuridine (Sigma, B5002) 8h prior to analysis were stained as described above followed by BrdU staining using BD BrdU Flow kit (BD Biosciences 552598) using manufacturer's instruction except that anti-BrdU FITC
(1/50, BD Biosciences 347583) was used instead of the one provided in the kit.
Data analysis was performed on a FACS Fortessa using the FACS DiVa software (BD Biosciences).
Mammary fat pad transplantation and analysis. One 1mm
were mated 4 weeks after the transplantation, and were killed 10 days later, at midpregnancy. Recipient glands were dissected, fixed and embedded in OCT for analysis by immunofluorescence. An outgrowth was defined as an epithelial structure comprising ducts and branchings.
Quantification of ER+ LCs
For quantification of proportion of ER+ cells within LCs in figure 1B , 3 mice per time point were analyzed and a total of 213, 349, 364, 1497 and 515 LCs were analyzed respectively for P7, 5w, 8w, pregn and invo.
Quantification of YFP+ in ER+ LCs
For quantification of proportion of YFP+ cells within ER+ LCs described in figure   2N , 4 mice were analyzed per time point and a total of respectively 2335 and 2485 ER+K8+ cells were analyzed.
Quantification of YFP+ in CD24+CD29low LCs
For quantification of YFP+ cells in CD24+CD29low population described in figure   2G and 2S, respectively 3, 4, 3 and 4 mice were analyzed for no, 3d, 4w and 10w time points and minimum 100000 CD24+CD29low cells were analyzed per sample.
For quantification of YFP+ cells in CD24+CD29low population described in figure   3J , respectively 3, 4, 4 and 4 mice were analyzed for 4w, pregn, invo and 2 nd invo time points and minimum 100000 CD24+CD29low cells were analyzed per sample.
Quantification of BrdU+ in LCs
Quantification of BrdU incorporation shown in figure 1C was performed in respectively 5 and 4 mice for 4w and 10w time points and a minimum of 10000 LCs were analyzed per sample.
Quantification of absolute number of LCs
For assessing the absolute number of LCs, total number of cells in samples was counted after cell preparation using Neubauer Improved cell counter (Blau Brand).
FACS staining was performed as described above, and fraction of the different populations compared to total cells was analyzed based on FACS analysis. Absolute number of LCs was calculated by multiplying the total number of cells counted by the fraction of the LCs compared to total cells on FACS analysis.
For quantification of number of CD24+CD29low cells at 4w and 10w described in Figure 2H , 2 inguinal glands (one #4 and one #5 glands) from female CD1 mice were processed per sample. 10 mice were analyzed per time point.
For quantification of number of CD24+CD29low and YFP+ CD24+CD29low cells in adult and pregnant mice, 3 thoracic glands (one #1, one #2 and one #3) from female 10w old virgin or 2w pregnant ERrtTA/TetOCRE/Rosa-YFP mice were processed.
Respectively 6 and 4 mice were processed in adult and pregnancy. 
